21.2.3
Acute Nephrotic Syndrome
Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 21, Renal Conditions.
Clinical Description
This condition is associated with proteinuria in excess of 3-3.5 g/1.73 m2 daily accompanied by hypoalbuminemia, oedema, hyperlipidemia and hypercoagulable state. Most often caused as a complication of a streptococcal infection. Usually manifests itself 1 – 5 weeks after an episode of pharyngitis, impetigo or infected scabies
Signs and Symptoms
- Oedema, low albumin, ascites, periorbital oedema, pleural effusion, genital oedema, protein energy malnutrition (especially in children)
Investigations
- Urinalysis, Urine microscopy (look for casts and check for Schistosoma ova), MPs and PCV, Electrolytes, Urea and Creatinine, Imaging on individual basis: renal USS, CXR, cardiacEcho
Non-pharmacological
- Monitor BP, urine output, weight
- Avoid added salt
- Treatment is usually supportive
Pharmacological
Adult
For control of oedema:
- Give Frusemide 40-80 mg 24 hourly (may require intravenous frusemide)
If hypertension is present:
- Treat accordingly (hypertension treatment section)
For control of proteinuria:
Use Angiotensin Converting enzyme inhibitors (i.e. Enalapril)
Note: Renal diseases can easily be mistaken for malnutrition
Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.